Coulter, GB
Catherine Coulter, Ballymena GB
Patent application number | Description | Published |
---|---|---|
20130012480 | CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(ME- THYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-- 2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME - A crystalline mono hydrochloride salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide is disclosed having improved stability. In addition, a crystalline mono mesylate salt and crystalline mono sulfate salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide are also disclosed having improved stability. A pharmaceutical composition containing the crystalline salts and methods of treating inflammatory skin disorders and bacterial infections comprising administering the crystalline salts are also disclosed. | 01-10-2013 |
20130302442 | METHODS OF USING (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(ME- THYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-- 2-CARBOXYLIC ACID AMIDE - A method of treating a bacterial infection, e.g., a bacterial infection with methicillin resistant | 11-14-2013 |
20140141075 | 5-AMINOSALICYLIC ACID CAPSULE FORMULATION - A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed. | 05-22-2014 |
20140370083 | 5-AMINOSALICYLIC ACID CAPSULE FORMULATION - A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed. | 12-18-2014 |
Steven Coulter, Bristol GB
Patent application number | Description | Published |
---|---|---|
20100044511 | Aircraft structure - An aircraft wing ( | 02-25-2010 |
20100127120 | Aircraft Structure - An aircraft control surface mounting structure comprising a cantilever rib ( | 05-27-2010 |
20120006942 | COUPLING ASSEMBLY - A coupling assembly for joining a first component to a second component, the assembly comprising a shaft for connecting to a first component, and a bracket including a mounting plate for connecting to a second component. The bracket has a bracket arm extending from the mounting plate, and a head having a through-bore on the bracket arm. The shaft is received in the through-bore. A setting device acts between the head and the shaft for setting of the position of the shaft with respect to the head in the axial direction of the shaft. The assembly further includes one or more spherical bearing surfaces, which permit self-alignment of the setting device to accommodate tilting of the shaft with respect to the head about a central point in two orthogonal directions. Also, a joint comprising a first component joined to a second component by one or more of the coupling assemblies. Also, a method of forming a joint using one or more of the coupling assemblies. | 01-12-2012 |
Thomas Coulter, Wantage GB
Patent application number | Description | Published |
---|---|---|
20110152232 | SULFONAMIDE COMPOUNDS AND USES THEREOF - Compounds that modulate GHS-R are described, for examples compounds formula (I) | 06-23-2011 |
Thomas S. Coulter, Wantage GB
Patent application number | Description | Published |
---|---|---|
20080221101 | Calcium receptor modulating agents - The present invention relates generally to compounds represented in Formula I, pharmaceutical compositions comprising them and methods of treating of diseases or disorders related to the function of the calcium sensing receptor. The invention also relates to processes for making such compounds and to intermediates useful in these processes. | 09-11-2008 |
Thomas S. Coulter, Oxfordshire GB
Patent application number | Description | Published |
---|---|---|
20110178133 | CALCIUM RECEPTOR MODULATING AGENTS - The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula I. | 07-21-2011 |
Thomas Stephen Coulter, Oxfordshire Wantage GB
Patent application number | Description | Published |
---|---|---|
20090215778 | Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives - Derivatives of pyrazolopyrimidine compounds represented by Formula I are disclosed: | 08-27-2009 |
Thomas Stephen Coulter, Abington GB
Patent application number | Description | Published |
---|---|---|
20120010220 | SPIROINDOLINEPIPERIDINE DERIVATIVES - Insecticidal, acaricidal, nematicidal or molluscicidal compounds of formula (I) | 01-12-2012 |
Thomas Stephen Coulter, Wantage GB
Patent application number | Description | Published |
---|---|---|
20090069323 | 11beta-hsdi inhibitors - The invention relates to compounds of formula (I) | 03-12-2009 |
20090163520 | MNK1 or MNK2 Inhibitors - The present invention relates to the use of pyrazolopyrimidine compounds for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 06-25-2009 |
20100056548 | THIENOPYRIMIDINES HAVING MNK1/MNK2 INHIBITING ACTIVITY FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 03-04-2010 |
20100105708 | PYRROLOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pyrrolopyrimidine compounds of the general formula (1) and pharmaceutical compositions comprising said pyrrolopyrimidine compounds. Moreover, the present invention relates to the use of the pyrrolopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 04-29-2010 |
20100143341 | THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions of general formula (I) comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 06-10-2010 |
20100234377 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE - The present invention relates to compounds of general formula (I): | 09-16-2010 |
Tom Coulter, Oxfordshire GB
Patent application number | Description | Published |
---|---|---|
20100137394 | PYRAZOLE INHIBITORS OF WNT SIGNALING - The invention provides inhibitors of Wnt signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein R1 to R7 and Z are as defined herein. | 06-03-2010 |